| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |